Allianz Asset Management Gmb H Homology Medicines, Inc. Transaction History

Allianz Asset Management Gmb H

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$9.17 - $14.8 $106,307 - $171,576	-11,593 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $152,246 - $226,833	-17,068 Reduced 59.55%	11,593 $131,000
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $200,420 - $334,504	-20,163 Reduced 41.3%	28,661 $307,000
Q2 2020 Aug 14, 2020	SELL	$12.07 - $19.34 $433,976 - $695,369	-35,955 Reduced 42.41%	48,824 $742,000
Q1 2020 May 14, 2020	BUY	$12.5 - $22.04 $44,500 - $78,462	3,560 Added 4.38%	84,779 $1.32 Million

Q4 2019 Feb 13, 2020	BUY	$11.42 - $22.19 $566,786 - $1.1 Million	49,631 Added 157.12%	81,219 $1.68 Million
Q3 2019 Nov 13, 2019	BUY	$14.74 - $22.28 $465,607 - $703,780	31,588 New	31,588 $572,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.